Early-Stage Perfusion MRI Correlates Significantly With Femoral Head Deformity in Children Under 6 Years of Age With

Joonoh Lee1, Ahan Mistry2, Jessica Cao1

  • 1University of Texas Southwestern Medical Center.

Insights

Perfusion MRI (pMRI) can predict Legg-Calvé-Perthes disease (LCPD) outcomes in children under 6. Early femoral head hypoperfusion on pMRI correlates with later deformity, aiding prognosis.

Area of Science:

  • Pediatric Orthopedics
  • Radiology
  • Medical Imaging

Background:

  • Legg-Calvé-Perthes disease (LCPD) onset before age 6 typically suggests good prognosis, yet some patients develop femoral head deformity.
  • No reliable early prognosticator exists for LCPD in this age group.
  • This study explores perfusion MRI (pMRI) for early outcome prediction in young LCPD patients.

Purpose of the Study:

  • To investigate the correlation between early-stage perfusion MRI (pMRI) findings and radiographic outcomes in pediatric Legg-Calvé-Perthes disease (LCPD).
  • To determine if early femoral head hypoperfusion on pMRI can predict long-term femoral head deformity (deformity index, epiphyseal index, sphericity deviation score).

Main Methods:

  • Multicenter retrospective review of LCPD patients with disease onset before age 6.
  • Inclusion criteria: pMRI at Waldenström stage I to IIa.
  • Analysis of demographic, pMRI, and radiographic data (DI, EI, SDS) with statistical correlation and ROC analysis.

Main Results:

  • Forty-one femoral heads (37 patients) analyzed; mean follow-up 4.1 years.
  • Significant correlation found between increasing femoral head hypoperfusion and greater deformity (higher DI, lower EI, higher SDS).
  • A 60% hypoperfusion threshold on pMRI predicted worse outcomes (higher DI, lower EI, higher SDS).

Conclusions:

  • Early-stage femoral head hypoperfusion on pMRI significantly correlates with radiographic outcomes in LCPD patients under 6.
  • A pMRI hypoperfusion threshold of 60% identifies hips at higher risk for deformity.
  • pMRI shows potential as an early prognostic marker for LCPD, guiding treatment decisions.
Abstract

Related Concept Videos